Last summer, Philips Respironics made a startling announcement. Some of the company’s medical devices had flaws that could expose patients to carcinogenic chemicals. The FDA recalled several Philips CPAP machines, ventilators, and BiPAP machines. After a recall, a manufacturer typically offers a repair, refund, or replacement. Philips said it would repair or replace all devices within a year of the recall. A year and a half later, thousands are still waiting for the promised resolution, and Philips now says repairs won’t be complete until 2023. Concerningly, some of the devices reworked after the 2021 recall might have some of the same issues.
BiPAP and CPAP machines are vital for people with sleep apnea, a condition that affects more than 20 million Americans. Someone with sleep apnea will stop breathing for a few seconds. This can happen up to 400 times a night, and when left untreated, the disorder can cause diabetes, high blood pressure, and heart failure. CPAP stands for continuous positive airway pressure, and the machine provides a constant air supply to keep airways open during sleep. Sleep apnea symptoms can improve with lifestyle changes, but a CPAP or BiPAP device is the most common treatment. For many, these machines are a lifesaver — sleep apnea patients who don’t receive treatment are more likely to die prematurely.
The Philips devices were recalled after the manufacturer received 30 medical device reports complaining about the machine’s sound abatement foam over ten years. CPAP machines are loud, and the foam helps reduce noise. Consumers told the company that the foam was degrading inside the devices and, in some cases, being inhaled or swallowed. Polyester-based polyurethane (PE-PUR) foam exposure can cause asthma, skin or respiratory tract irritation, and headaches. PE-PUR foam contains carcinogenic chemicals linked to lung cancer, kidney failure, and non-Hodgkin’s lymphoma.
↧
Trending Articles
More Pages to Explore .....